Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2023 Jan;160(1):161-166.
doi: 10.1002/ijgo.14359. Epub 2022 Aug 8.

Should pregnant women be screened for SARS-CoV-2 infection? A prospective multicenter cohort study

Enav Yefet  1   2 , Manal Massalha  3   4 , Adi Alter  1 , Amit Gal Harnik  1 , Sally Hosari Mahamed  3 , Lia Novick  1 , Malak Wattad  3 , Jawad Sakas  1 , Shira Baram  3 , Amir Weiss  3   4 , Rula Iskander  3 , Avi Peretz  2   5 , Orit Rozenberg  6 , Johnny S Younis  1   2 , Yuri Perlitz  1   2 , Zohar Nachum  3   4
Affiliations
Multicenter Study

Should pregnant women be screened for SARS-CoV-2 infection? A prospective multicenter cohort study

Enav Yefet et al. Int J Gynaecol Obstet. 2023 Jan.

Abstract

Objective: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ranges from asymptomatic to severe infection. We aimed to compare the prevalence of COVID-19 in asymptomatic pregnant versus nonpregnant women in order to establish recommendations for a COVID-19 screening strategy.

Methods: A prospective multicenter cohort study was conducted. Asymptomatic pregnant or nonpregnant women after March 2020 (the time when COVID-19 was first detected in north Israel) were tested for SARS-CoV-2 using nasopharyngeal reverse transcription polymerase chain reaction test, anti-nucleocapsid IgG, and anti-spike IgG. Diagnosis was made if at least one test result was positive. Pregnant women were tested between 34 and 42 weeks, mostly at birth.

Results: Among the 297 participating women, 152 were pregnant and 145 were nonpregnant. The prevalence of asymptomatic COVID-19 was similar between the groups (4 [2.6%] and 8 [5.5%], respectively; P = 0.2). All women with COVID-19 delivered healthy appropriate-for-gestational-age babies without malformations, at term.

Conclusions: The rate of asymptomatic COVID-19 in pregnant women is low and comparable to the rate among nonpregnant women. Pregnancy outcomes are favorable. Future screening programs should consider that one of 25 screened asymptomatic women will be positive.

Keywords: COVID-19; SARS-CoV-2; pregnancy; screening.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

References

    1. Symptomatic women of reproductive age with laboratory‐confirmed SARS‐CoV‐2 infection by pregnancy status – United States, January 22‐October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1641‐1647. - PMC - PubMed
    1. Ellington S, Strid P, Tong VT, et al. Characteristics of women of reproductive age with laboratory‐confirmed SARS‐CoV‐2 infection by pregnancy status – United States, January 22‐June 7, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:769‐775. - PMC - PubMed
    1. Delahoy MJ, Whitaker M, O'Halloran A, et al. Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory‐confirmed COVID‐19 – COVID‐NET, 13 States, March 1‐August 22, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1347‐1354. - PMC - PubMed
    1. Woodworth KR, Olsen EO, Neelam V, et al. Birth and infant outcomes following laboratory‐confirmed SARS‐CoV‐2 infection in pregnancy – SET‐NET, 16 jurisdictions, March 29‐October 14, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1635‐1640. - PMC - PubMed
    1. Villar J, Ariff S, Gunier RB, et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID‐19 infection: the INTERCOVID multinational cohort study. Am J JAMA Pediatr. 2021;175:817‐826. - PMC - PubMed

Publication types

Substances